Clinical Trial ECOGTHNR1008


A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors

Principal Investigator(s)

Kenneth Niermann


  • Protocol No. ECOGTHNR1008
  • Open Date: 09/07/2012
  • Staging: Phase II
  • Age Group: Adults
  • Scope: National
  • Objective: Determine the feasibility of conducting a cooperative group prospective clinical trial in patients with resected malignant salivary gland tumors; Acquire preliminary efficacy data comparing postoperative radiotherapy alone to concurrent chemotherapy and radiation using weekly cisplatin.
  • Disease Sites: Head/Neck
  • Therapies: Chemotherapy - cytotoxic; Radiotherapy
  • Drugs: Cisplatin
  • Participating Institutions: Vanderbilt University
  • National Clinical Trial ID: NCT01220583
  • Secondary Protocol No: RTOG-1008 (site# 357)



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.